Mast cell infiltrates in vulvodynia represent secondary and idiopathic mast cell hyperplasias

APMIS

Volumn 123, Issue 5, 2015, Pages 452-456

  Regauer, Sigrid ^a   Eberz, Barbara ^b   Beham Schmid, Christine ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b General Gynecology Practice   (Austria)

Author keywords

C kit mutation D816V; CD25 expression; Mast cell activation; Mast cell hyperplasia; Spindled mast cells; Vulvar pain

Indexed keywords

ANTIHISTAMINIC AGENT; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LIDOCAINE; STEM CELL FACTOR RECEPTOR; TRYPTASE; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; CANDIDIASIS; CELL HYPERPLASIA; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MAST CELL; MAST CELL DEGRANULATION; MASTOCYTOSIS; PAPILLOMAVIRUS INFECTION; PHYSIOTHERAPY; POINT MUTATION; PRIORITY JOURNAL; T LYMPHOCYTE; VULVODYNIA; ADOLESCENT; BLOOD; ENZYMOLOGY; GENETICS; HYPERPLASIA; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; FEMALE; HUMANS; HYPERPLASIA; MAST CELLS; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; TRYPTASES; VULVODYNIA; YOUNG ADULT;

EID: 84928256317     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12372     Document Type: Article

References (20)

1. Bachmann GA, Rosen R, Pinn VW, Utian WH, Ayers C, Basson R, et al. Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med 2006;51:447-56.
2. Nunns D, Mandal D, Byrne M, McLelland J, Rani R, Cullimore J, et al. Guidelines for the management of vulvodynia. Br J Dermatol 2010;162:1180-5.
3. Bornstein J, Goldschmid N, Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest 2004;58:171-8.
4. Regauer S, Eberz B Diagnosis and management of vulvodynia should include biopsy and histological examination. Br J Dermatol 2010;163:663-5. author reply 665-6.
5. Chatterjea D, Martinov T. Mast cells: versatile gatekeepers of pain. Mol Immunol 2015;63:38-44.
6. Galli SJ, Tsai M. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci 2008;49:7-19.
7. Valent P, Akin C, Arock M, Brockow K, Butterfield JH, Carter MC, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 2012;157:215-25.
8. Horny HP, Metcalfe DD, Bennett BJ, Bain JB, Akin C, Escribano L, et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. World Health Organization of Classification of Tumours of Hematopoetic and Lymphoid Tissues. 4th edn, Lyon, France: IARC Press, 2008: 54-63.
9. Debiec-Rychter M, Dumez H, Judson I, Wasag B, Verweij J, Brown M, et al. Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2004;40:689-95.
10. Torresani C, Bellafiore S, De Panfilis G. Chronic urticaria is usually associated with fibromyalgia syndrome. Acta Derm Venereol 2009;89:389-92.
11. Regauer S, Beham-Schmid C. Benign mast cell hyperplasia and atypical mast cell infiltrates in penile lichen planus in adult men. Histol Histopathol 2014;29:1017-25.
12. Harlow BL, He W, Nguyen RH. Allergic reactions and risk of vulvodynia. Ann Epidemiol 2009;19:771-7.
13. Nguyen RH, Swanson D, Harlow BL. Urogenital infections in relation to the occurrence of vulvodynia. J Reprod Med 2009;54:385-92.
14. Forsythe P, Bienenstock J. The mast cell-nerve functional unit: a key component of physiologic and pathophysiologic responses. Chem Immunol Allergy 2012;98:196-221.
15. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos DN, Zhang B, et al. Mast cells and inflammation. Biochim Biophys Acta 2012;1822:21-33.
16. Verri WA, Cunha TM, Parada CA, Poole D, Cunha FQ, Ferreira SH. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther 2006;112:116-38.
17. Lundequist A, Pejler G. Biological implications of preformed mast cell mediators. Cell Mol Life Sci 2011;68:965-75.
18. Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Small MJ, Gelone SP. Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study. Sex Transm Infect 2001;77:53-7.
19. Ma Z, Tovar JP, Kwong KY, Paek D. Pimecrolimus induces apoptosis of mast cells in a murine model of cutaneous mastocytosis. Int Arch Allergy Immunol 2010;153:413-8.
20. Egesi A, Sun G, Khachemoune A, Rashid RM. Statins in skin: research and rediscovery, from psoriasis to sclerosis. J Drugs Dermatol 2010;9:921-7.